Teva to acquire distributor Anda from Allergan

JERUSALEM and DUBLIN — Teva will be acquiring from Allergan its distribution business Anda, the two companies announced Tuesday. The $500 million deal will see Teva bringing under its wing the fourth-largest generics distributor in the United States. 

 

“Anda is a natural fit into our business in general and our extensive supply chain network in particular,” Teva president and CEO global generic medicines Siggi Olafsson said. “This strategic move enables us and our customers to improve capabilities and flexibility given the changes the pharmaceutical industry is currently undergoing, in order to provide access to more patients throughout the country. Additionally, both Teva and Anda’s customers will benefit from our ability as the largest producer of medicines in the world to leverage our size and scale.”

 

Anda’s generics, branded and OTC pharmaceutical distribution encompasses more than 300 manufacturers and the products reach retail and chain pharmacies, nursing homes, mail-order pharmacies, hospitals, clinics and physicians offices. Anda is expected to generate more than $1 billion in third-party net revenue for the full-year 2016. The acquisition will bring three distribution centers with more than 650 total employees to Teva, one in Olive Branch, Miss.; another in Weston, Fla.; and third in Groveport, Ohio.

 

“Joining Teva opens a new world of possibilities for Anda, especially as the appropriate utilization of generic medicines remains the most effective means by which to ensure broad patient access,” Anda president and CEO Charles D. Phillips said. “We look forward to the opportunity to utilize the Teva network to the advantage of our customers and patients across the country.”

 

The companies expect the deal to close in the second half of 2016.